Literature DB >> 11309284

The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.

M McMahon1, K Itoh, M Yamamoto, S A Chanas, C J Henderson, L I McLellan, C R Wolf, C Cavin, J D Hayes.   

Abstract

Northern blotting has shown that mouse small intestine contains relatively large amounts of the nuclear factor-E2 p45-related factor (Nrf) 2 transcription factor but relatively little Nrf1. Regulation of intestinal antioxidant and detoxication enzymes by Nrf2 has been assessed using a mouse line bearing a targeted disruption of the gene encoding this factor. Both Nrf2-/- and Nrf2+/+ mice were fed a control diet or one supplemented with either synthetic cancer chemopreventive agents [butylated hydroxyanisole (BHA), ethoxyquin (EQ), or oltipraz] or phytochemicals [indole-3-carbinol, cafestol and kahweol palmitate, sulforaphane, coumarin (CMRN), or alpha-angelicalactone]. The constitutive level of NAD(P)H:quinone oxidoreductase (NQO) and glutathione S-transferase (GST) enzyme activities in cytosols from small intestine was typically found to be between 30% and 70% lower in samples prepared from Nrf2 mutant mice fed a control diet than in equivalent samples from Nrf2+/+ mice. Most of the chemopreventive agents included in this study induced NQO and GST enzyme activities in the small intestine of Nrf2+/+ mice. Increases of between 2.7- and 6.2-fold were observed in wild-type animals fed diets supplemented with BHA or EQ; increases of about 2-fold were observed with a mixture of cafestol and kahweol palmitate, CMRN, or alpha-angelicalactone; and increases of 1.5-fold were measured with sulforaphane. Immunoblotting confirmed that in the small intestine, the constitutive level of NQO1 is lower in the Nrf2-/- mouse, and it also showed that induction of the oxidoreductase was substantially diminished in the mutant mouse. Immunoblotting class-alpha and class-mu GST showed that constitutive expression of most transferase subunits is also reduced in the small intestine of Nrf2 mutant mice. Significantly, induction of class-alpha and class-mu GST by EQ, BHA, or CMRN is apparent in the gene knockout animal. No consistent change in the constitutive levels of the catalytic heavy subunit of gamma-glutamylcysteinyl synthetase (GCS(h)) was observed in the small intestine of Nrf2-/- mice. However, although the expression of GCS(h) was found to be increased dramatically in the small intestine of Nrf2+/+ mice by dietary BHA or EQ, this induction was essentially abolished in the knockout mice. It is apparent that Nrf2 influences both constitutive and inducible expression of intestinal antioxidant and detoxication proteins in a gene-specific fashion. Immunohistochemistry revealed that induction of NQO1, class-alpha GST, and GCS(h) occurs primarily in epithelial cells of the small intestine. This suggests that the variation in inducibility of NQO1, Gsta1/2, and GCS(h) in the mutant mouse is not attributable to the expression of the enzymes in distinct cell types but rather to differences in the dependency of these genes on Nrf2 for induction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309284

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  203 in total

1.  MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism.

Authors:  Muhua Yang; Yuan Yao; Gabriel Eades; Yongshu Zhang; Qun Zhou
Journal:  Breast Cancer Res Treat       Date:  2011-06-03       Impact factor: 4.872

2.  Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress.

Authors:  Donna D Zhang; Mark Hannink
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

3.  Nrf2-dependent induction of proteasome and Pa28αβ regulator are required for adaptation to oxidative stress.

Authors:  Andrew M Pickering; Robert A Linder; Hongqiao Zhang; Henry J Forman; Kelvin J A Davies
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

4.  Transcription factors in the cellular signaling network as prime targets of chemopreventive phytochemicals.

Authors:  Young-Joon Surh
Journal:  Cancer Res Treat       Date:  2004-10-30       Impact factor: 4.679

5.  Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells.

Authors:  Sujit Nair; Avantika Barve; Tin-Oo Khor; Guo-xiang Shen; Wen Lin; Jefferson Y Chan; Li Cai; Ah-Ng Kong
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

6.  Genetic variation in the Nrf2 promoter associates with defective spermatogenesis in humans.

Authors:  Bolan Yu; Huanlan Lin; Lixia Yang; Kang Chen; Haihua Luo; Jianqiao Liu; Xingcheng Gao; Xuefeng Xia; Zhaofeng Huang
Journal:  J Mol Med (Berl)       Date:  2012-05-31       Impact factor: 4.599

7.  NRF2 activation with Protandim attenuates salt-induced vascular dysfunction and microvascular rarefaction.

Authors:  Jessica R C Priestley; Katie E Fink; Joe M McCord; Julian H Lombard
Journal:  Microcirculation       Date:  2019-06-19       Impact factor: 2.628

8.  Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity.

Authors:  Xiao-Jun Wang; Zheng Sun; Weimin Chen; Kylee E Eblin; Jay A Gandolfi; Donna D Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-07       Impact factor: 4.219

9.  Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms.

Authors:  Andrea M Vincent; Koichi Kato; Lisa L McLean; Mary E Soules; Eva L Feldman
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

Review 10.  The cancer chemopreventive actions of phytochemicals derived from glucosinolates.

Authors:  John D Hayes; Michael O Kelleher; Ian M Eggleston
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.